ClosedPublished 26 Aug 2024

Insud Pharma, S.L. /
Agile Therapeutics, Inc.

Insud Pharma completes merger with Agile Therapeutics

Buy side: Insud Pharma, S.L.
Buy sideInsud Pharma, S.L.
Target: Agile Therapeutics, Inc.
TargetAgile Therapeutics, Inc.
Source · 26 Aug 2024Source-verified
Buy side: Insud Pharma, S.L.
Buy sideInsud Pharma, S.L.
Target: Agile Therapeutics, Inc.
TargetAgile Therapeutics, Inc.
01 / BuyerInsud Pharma, S.L.
02 / TargetAgile Therapeutics, Inc.
Source-verified
01

What happened

Insud Pharma, S.L. completed its merger with Agile Therapeutics, Inc. on August 26, 2024. Agile Therapeutics became an indirect wholly owned subsidiary of Insud Pharma, S.L.

Agile Therapeutics common stockholders were entitled to receive $1.52 per share in cash, subject to applicable withholding taxes.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Insud Pharma completes merger with Agile Therapeutics

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.